Works matching DE "VANISHING white matter disease"
Results: 13
Axonal abnormalities in vanishing white matter.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 4, p. 429, doi. 10.1002/acn3.540
- By:
- Publication type:
- Article
Impaired Eukaryotic Translation Initiation Factor 2B Activity Specifically in Oligodendrocytes Reproduces the Pathology of Vanishing White Matter Disease in Mice.
- Published in:
- Journal of Neuroscience, 2014, v. 34, n. 36, p. 12182, doi. 10.1523/JNEUROSCI.1373-14.2014
- By:
- Publication type:
- Article
Natural History of Vanishing White Matter.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Novel Mutation in the EIF2B4 Gene Associated with Leukoencephalopathy with Vanishing White Matter.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4.
- Published in:
- Clinical Genetics, 2015, v. 88, n. 4, p. 401, doi. 10.1111/cge.12554
- By:
- Publication type:
- Article
Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.
- Published in:
- Journal of Neurochemistry, 2017, v. 141, n. 5, p. 694, doi. 10.1111/jnc.14024
- By:
- Publication type:
- Article
Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.
- Published in:
- Journal of Neurochemistry, 2015, v. 134, n. 3, p. 513, doi. 10.1111/jnc.13142
- By:
- Publication type:
- Article
Astrocytes are central in the pathomechanisms of vanishing white matter.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions.
- Published in:
- Frontiers in Cellular Neuroscience, 2017, p. 1, doi. 10.3389/fncel.2017.00411
- By:
- Publication type:
- Article
Vanishing white matter: a leukodystrophy due to astrocytic dysfunction.
- Published in:
- Brain Pathology, 2018, v. 28, n. 3, p. 408, doi. 10.1111/bpa.12606
- By:
- Publication type:
- Article
Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
- Published in:
- BMC Medical Genetics, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12881-015-0204-z
- By:
- Publication type:
- Article
Bergmann glia translocation: a new disease marker for vanishing white matter identifies therapeutic effects of Guanabenz treatment.
- Published in:
- Neuropathology & Applied Neurobiology, 2018, v. 44, n. 4, p. 391, doi. 10.1111/nan.12411
- By:
- Publication type:
- Article
Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy.
- Published in:
- Frontiers in Molecular Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnmol.2018.00336
- By:
- Publication type:
- Article